Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 86, Issue 1, Pages 109-113Publisher
WILEY
DOI: 10.1038/clpt.2009.39
Keywords
-
Categories
Funding
- NIH [U01GM61373]
Ask authors/readers for more resources
The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available